Broad Market Rally With Biotech Lagging Biotech stocks showed some strength today with a lively tape but lagged the broader market. The S&P 500 (SPY) continued a rally that began on 2/11 and is now up 2.26% over one month, 4.39% over
February 22, 2016
The Dow was more or less flat on Friday. After all the excitement early in the year, stock markets seemed to have settled down. In our upcoming issue of The Bill Bonner Letter, we explore the strange territory of “NIRP” –
On the heels of weakness in the rest of the world’s PMIs, US Manufacturing just printed 51.0 (missing expectations of 52.4) and tumbling to its lowest since October 2012… followed rapidly by Bernanke hinting at QE3. While Markit does ‘blame the
USDJPY: With the pair remaining weak and following through lower on Tuesday trading session, further weakness is envisaged. On the downside, support comes in at the 111.50 level where a break if seen will aim at the 111.00 level. A
Did you know that there are some U.S. states that have already officially fallen into recession? Economic activity all over the planet is in the process of slowing down, and there are some areas of the country that are really starting
Today shares of Chimerix (CMRX) fell by 40% after the company announced that it had to halt two phase 3 trials due to insufficient efficacy. The company reported results on its phase 3 SUPPRESS TRIAL, which recruited a total of
I sat down with Bill Holter of JSMineset, to see what his research is telling him about the opening of 2016 and why the markets have been in free fall. What Bill shares should get your attention and paint a realistic
It has become cliché that commentary continues toward the increasingly absurd at the expense of the obvious and all because Janet Yellen says there can’t possibly be anything wrong. The degree to which the broader markets agree in that sense
And the dividend hits just keep on coming. Moments ago, Australian mining giant BHP Billiton announced that underlying H1 profit plunged 92% from $4.9 billion to just $412 million, well below the lowest forecast and certainly below the consensus estimate
Our benchmark S&P 500 surged at the open, rising to an unusually narrow trading range for the rest of the session. It closed with a 1.45% advance, returning to rally mode after a two-session pause. The index is out of
